You've been vaccinated; can you now safely see your friends and family? New research hints that vaccinated people may be less likely to transmit the coronavirus, but they are not 100% in the clear.
Rigor académico, oficio periodístico
Artículos sobre Pfizer vaccine
Mostrando 1 - 20 de 27 artículos
The clock starts ticking once the vaccine leaves the freezer. Here's what to expect.
Over 130 million doses have already been administered worldwide. It's early days, but the signs are promising in places like Israel and the UK.
Americans with excess weight and obesity have been hit hard by COVID-19. Now there is reason to believe they may not get the same protection from the vaccines.
Vaccine hesitancy will not go away fast. In fact, there are parallels in the physical world to how quickly or slowly an object returns to its normal state.
A recommendation from a German vaccine advisory body not to give the AstraZeneca vaccine to people aged over 65 has caused concern. But we should interpret this advice with caution.
Tensions run high as EU vaccine deliveries fall behind schedule, while new vaccines are being created to handle mutant viral strains.
Two pharmacists involved in COVID-19 vaccine preparation explain the role pharmacists are poised to play in expanding vaccine access.
Perhaps you've heard mRNA vaccines cause autoimmune disease, or connect you to the internet. Now the Pfizer vaccine has been approved in Australia, it's important we iron out these misconceptions.
Historically, we immunized children against diseases like polio that were a clear danger to them, but COVID-19 is usually mild in children. However, herd immunity is unlikely without vaccinating kids.
Rollout of COVID-19 vaccines has begun. But getting the jab doesn't mean abandoning masks, distancing and handwashing. Here's why the current preventive measures must continue post-vaccine.
Two in five Americans say they don't want a COVID-19 vaccine, which is a problem. Finding out what Americans do want from a vaccine might help.
The shipment of goods to suppliers has become technologically sophisticated. Delays in getting out the COVID-19 vaccine to people show that the breakdowns come down to something more basic.
Australia's expedited plan to start dishing out COVID jabs in mid-late February will call for NASA-like logistical organisation. And ideally, no more clusters of infections to distract frontline workers.
A serious allergic reaction was reported in a health care worker in Alaska after she received the COVID-19 vaccine. Does this mean that people with allergies need to be concerned? An expert answers.
The development of multiple vaccines against the virus that causes COVID-19 has been hailed as the breakthrough of 2020. But there were many more supporting discoveries that made this possible.
As the coronavirus rages, a vaccine finally is available for certain groups of people and will soon be ready for other groups. But there are plenty of questions. A doctor answers five here.
We should applaud drug companies for developing COVID-19 vaccines in record time, but let’s not be under any illusion about the profits that are motivating them.
Reports of two UK health workers having allergic reactions after receiving Pfizer's COVID vaccine have led to safety warnings for others at risk of anaphylaxis.
If supplies of COVID-19 vaccine are initially limited, who should be vaccinated first? A mathematical model shows when and why it’s best to start with the young, and when older people should go first.
Principales colaboradores
-
Associate Professor, Discipline of Childhood and Adolescent Health, University of Sydney
-
Professor in Global Public Health and Director of the Mitchell Institute, Victoria University
-
Professor of Immunology and Associate Provost, Research Partnerships, Victoria University
-
Director, Center for Public Interest Communications, University of Florida
-
Professor of Epidemiology Healthcare Infection and Infectious Diseases Control, UNSW
-
John F. Smith Memorial Professor of Operations Management, University of Massachusetts Amherst
-
Professor Emeritus of Health Policy and Management, York University, Emergency Physician at University Health Network, Associate Professor of Family and Community Medicine, University of Toronto
-
Professor & Director, Global Ecological Change & Sustainability Laboratory, University of Guelph
-
Assistant Professor of Political Science, Oklahoma State University
-
Director of the Digital Health Enterprise Zone (DHEZ), University of Bradford, Reader in Health Service Operations, University of Bradford
-
Postdoctoral research associate, University of Florida
-
Associate Director of Microbiology, University of California San Diego
-
Director of Skills Education and Clinical Assistant Professor of Pharmacy Practice, Binghamton University, State University of New York
-
Project Coordinator & Staff Scientist, Vanderbilt University Medical Center, Vanderbilt University
-
Vice-Chancellor's Research Fellow, School of Health and Biomedical Sciences, RMIT University
